SEC ownership of Anixa Biosciences Inc

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000715446.

Comparable stake leader

Amit Kumar

Disclosed value leader

Amit Kumar

Comparable rows

2/50

Latest evidence

23 Oct 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
2 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Amit Kumar
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
23 Oct 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0000715446
Issuer location
San Jose, CA

Ownership snapshot

Top shareholders of Anixa Biosciences Inc (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Amit Kumar
Disclosed value leader
Amit Kumar
Comparable rows
2/50
Latest evidence
23 Oct 2026
13D/G 3/4/5 13F Lead comparable stake: 16% 48 rows are not safely comparable across share classes. 13D/G row: Amit Kumar Showing 1-8 of 50 holder rows.

Quick read

Amit Kumar leads the comparable SEC ownership view at 16%.

2 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Amit Kumar's linked filing trail.
Comparable ownership Top 2
Amit Kumar 16%
Michael J. Catelani 7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Amit Kumar
13D/G 3/4/5
Chief Executive Officer, Director
16%
Reported 13D/G · 04 Jun 2025
$16,667,362
6,173,097 shares
+$1,403,336 04 Jun 2025
Michael J. Catelani
13D/G 3/4/5
Michael Catelani · President, COO, & CFO
7%
Reported 13D/G · 05 Jan 2026
$10,662,205
2,468,103 shares
$0 05 Jan 2026
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$3,723,586
1,329,852 shares
— 30 Jun 2026
Lewis H. Titterton Jr.
3/4/5
Director
—
mixed-class rows
$3,140,928
1,079,003 shares
mixed-class rows
+$241,348 23 Oct 2026
UBS Group AG
13F
Company
13F
—
denominator unverified
$1,639,204
585,430 shares
— 30 Jun 2026
Laird Norton Wetherby Trust Company, LLC
13F
Company
13F
—
denominator unverified
$1,620,436
578,727 shares
— 30 Jun 2026
D.A. DAVIDSON & CO.
13F
Company
13F
—
denominator unverified
$1,509,962
539,272 shares
— 30 Jun 2026
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$1,006,247
359,194 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to buying over the last 12 months. Net value: +$521,772.

Buys
$521,772
Insiders: 4
Sells
$0
Insiders: 0
Net
+$521,772
Shares: +180,357
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 180,357 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 105,536 0 $291,587 $0 +$291,587
3-6 64,821 0 $199,785 $0 +$199,785
6-9 0 0 $0 $0 $0
9-12 10,000 0 $30,400 $0 +$30,400

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-5 of 5 reporting-owner rows connected to Anixa Biosciences Inc. Open a relationship link for the CIK-to-CIK filing trail.

Rows
5
Largest Forms 3/4/5 holder
Lewis H. Titterton Jr.
Net 12M change
+$521.77KFull value: +$521,772 · USD · 12-month change
Latest report
30 Oct 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Lewis H. Titterton Jr. Director $3,140,928 +$241,348 +8.3% Filing P/S 23 Oct 2026
Amit Kumar Chief Executive Officer, Director $2,171,450 +$220,604 +11% Filing P/S 30 Oct 2026
Arnold M. Baskies Director $387,978 +$44,200 +13% Filing P/S 24 Sep 2026
Michael J. Catelani President, COO, & CFO $142,000 +$15,620 +12% Filing P/S 30 Sep 2026
Emily Gottschalk Director Mixed 05 Jan 2026

Recent insider transactions for Anixa Biosciences Inc

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Amit Kumar ANIX Common Stock Purchase 0.74% $15,850 $3.17 5,000 685,000 30 Oct 2026 Direct
Lewis H. Titterton Jr. ANIX Common Stock Purchase 0.76% $23,840 $2.98 8,000 1,054,003 23 Oct 2026 Direct
Amit Kumar ANIX Common Stock Purchase 1.19% $21,760 $2.72 8,000 680,000 22 Oct 2026 Direct
Michael J. Catelani ANIX Common Stock Purchase 12.4% $15,620 $2.84 5,500 50,000 30 Sep 2026 Direct
Amit Kumar ANIX Common Stock Purchase 1.05% $19,460 $2.78 7,000 672,000 24 Sep 2026 Direct
Arnold M. Baskies ANIX Common Stock Purchase 3.69% $13,800 $2.76 5,000 140,572 24 Sep 2026 Direct
Lewis H. Titterton Jr. ANIX Common Stock Purchase 4.92% $131,907 $2.69 49,036 1,046,003 23 Sep 2026 Direct
Amit Kumar ANIX Common Stock Purchase 0.45% $8,250 $2.75 3,000 665,000 10 Sep 2026 Direct
Lewis H. Titterton Jr. ANIX Common Stock Purchase 1.01% $27,300 $2.73 10,000 996,967 10 Sep 2026 Direct
Amit Kumar ANIX Common Stock Purchase 0.76% $13,800 $2.76 5,000 662,000 10 Sep 2026 Direct
Amit Kumar ANIX Common Stock Purchase 0.77% $17,350 $3.47 5,000 657,000 31 Jul 2026 Direct
Arnold M. Baskies ANIX Common Stock Tax liability -3.85% -5,428 135,572 27 Jul 2026 Direct
Arnold M. Baskies ANIX Common Stock Options Exercise 4.44% 6,000 141,000 27 Jul 2026 Direct
Arnold M. Baskies ANIX Employee Stock Option (Right to Buy) Options Exercise -100% -6,000 0 27 Jul 2026 Direct
Amit Kumar ANIX Common Stock Purchase 0.77% $17,200 $3.44 5,000 652,000 27 Jul 2026 Direct
Amit Kumar ANIX Common Stock Purchase 0.5% $10,744 $3.37 3,188 647,000 27 Jul 2026 Direct
Amit Kumar ANIX Common Stock Purchase 0.47% $11,190 $3.73 3,000 643,812 24 Jul 2026 Direct
Amit Kumar ANIX Common Stock Purchase 0.79% $17,300 $3.46 5,000 640,812 20 Jul 2026 Direct
Lewis H. Titterton Jr. ANIX Common Stock Purchase 1.23% $41,640 $3.47 12,000 986,967 20 Jul 2026 Direct
Lewis H. Titterton Jr. ANIX Common Stock Purchase 0.29% $9,174 $3.28 2,797 974,967 15 Jul 2026 Direct
Amit Kumar ANIX Common Stock Purchase 0.79% $15,200 $3.04 5,000 635,812 10 Jul 2026 Direct
Lewis H. Titterton Jr. ANIX Common Stock Purchase 0.29% $7,487 $2.64 2,836 972,170 16 Jun 2026 Direct
Amit Kumar ANIX Common Stock Purchase 3.44% $52,500 $2.50 21,000 630,812 12 Jun 2026 Direct
Arnold M. Baskies ANIX Common Stock Purchase 8% $30,400 $3.04 10,000 135,000 28 Jan 2026 Direct
Lewis H. Titterton Jr. ANIX Employee Stock Option Award 25,000 25,000 05 Jan 2026 Direct
Amit Kumar ANIX Employee Stock Option Award 350,000 350,000 05 Jan 2026 Direct
Emily Gottschalk ANIX Employee Stock Option Award 25,000 25,000 05 Jan 2026 Direct
Michael J. Catelani ANIX Employee Stock Option Award 175,000 175,000 05 Jan 2026 Direct
Arnold M. Baskies ANIX Employee Stock Option Award 25,000 25,000 05 Jan 2026 Direct
Lewis H. Titterton Jr. ANIX Common Stock Options Exercise 1.68% 16,000 969,334 15 Dec 2025 Direct
Lewis H. Titterton Jr. ANIX Employee Stock Option Options Exercise -100% -16,000 0 15 Dec 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .